Synonyms: BLU-222 | BLU222
Compound class:
Synthetic organic
Comment: BLU-222 is an oral cyclin-dependent kinase 2 (CDK2)-selective inhibitor from Blueprint Therapeutics. Its chemical structure was revealed during the first time disclosures session at the 2024 ACS spring meeting in New Orleans. BLU-222 is proposed to target solid tumours with CDK2/cyclin E1 amplifications that drive G1/S progression, such as certain ovarian cancers. The chemical structure of BLU-222 is identical to that for the INN cirtociclib (proposed list 132, Feb. 2025).
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[3-(difluoromethoxy)-1H-pyrazol-5-yl]-1-(oxan-4-ylmethyl)pyrazolo[3,4-b]pyrazin-6-amine |
International Nonproprietary Names ![]() |
|
INN number | INN |
13479 | cirtociclib |
Synonyms ![]() |
BLU-222 | BLU222 |
Database Links ![]() |
|
CAS Registry No. | 2888704-84-3 (source: WHO INN record) |
GtoPdb PubChem SID | 496703267 |
PubChem CID | 168752082 |
Search Google for chemical match using the InChIKey | IFJSYTKOMJJYNP-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | IFJSYTKOMJJYNP |
Search PubMed clinical trials | cirtociclib |
Search PubMed titles | cirtociclib |
Search PubMed titles/abstracts | cirtociclib |
UniChem Compound Search for chemical match using the InChIKey | IFJSYTKOMJJYNP-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | IFJSYTKOMJJYNP-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
BLU-222 (links to external site)
Cat. No. HY-160701 |